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ABSTRACT
Objective: Iranian breast cancer patients are relatively younger than their Western
counterparts. The objective of the present study was to investigate risk factors for breast
cancer in Iranian women and compare it with other data driven from other studies.
Methods: A study was conducted in April 2008 in Tehran, Iran. Demographical data and risk
factor related information, including data from their mammograms were collected using a
questionnaire.
Results: In all, 109 participants were interviewed. The mean age of participants was 40.48 ±
0.56 years. 1.8% of women were unmarried, while 78% were married and 20.2% were divorced/
widowed. The mean age for menarche was 13.34 ±1.47 years and 46.89±4.98 for the
menopause, respectively. The mean parity time was 2.36±1.13 and breastfeeding in women
was 23.27±14.16 months. About 5.5% of the participants used oral contraceptive as a method
for contraception. 8.3% of women experienced menopause, at the mean age of 46.89±4.98.
33.3% of menopaused women, used Hormone Replace Therapy (HRT).Moreover, 8.3% of women
had a positive history of breast cancer in their family. Of those women on whom mammography
was done, 10.1% had breast mass in radiological findings, mostly in favour of fibrocystic change.
In 20.2% of participants, further investigation was advised.
Conclusion: The findings of the present study were in accordance with other studies done in
Iran and in some aspects in tune with other studies about breast cancer in other countries.
However, more multicentric larger scale studies should be conducted in Iran to determine a
pattern for breast cancer in Iranian women.
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INTRODUCTION
Public health programs aim to reduce
morbidity and mortality from various diseases
through primary and secondary prevention
strategies.  Primary prevention strategies focus
on modifying lifestyle factors that may reduce
risk, such as exercising regularly and maintain-
ing a healthy weight. Secondary prevention
strategies focus on early detection of cancer by
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promoting regular screening and awareness of
symptoms of cancer in order to provide
medical intervention at early, curable stages of
disease.
However, these strategies are not 100%
effective, and currently no known prevention
strategies will completely eliminate all risk for
developing or dying from breast cancer. In the
population of Iranian woman, it is expected that
conservatively about 1.5 out of every 1,000
women will have breast cancer, comparing with
the range of breast cancer from other countries.1-
3 According to the American Cancer Society,
approximately 200,000 cases of breast cancer
and 23,000 cases of ovarian cancer are diagnosed
in the United States each year.4 While this preva-
lence rate is lower than breast cancer prevalence
in older women, breast cancer in younger
women remains a tremendous clinical challenge
and is the leading cause of cancer death for
women between the ages of 15 and 54.5
In absolute numbers, approximately 12,000
new cases are diagnosed each year in women
under age 40.6 Public health programs aim to
reduce morbidity and mortality from these dis-
eases through primary and secondary preven-
tion strategies.  Primary prevention strategies
focus on modifying lifestyle factors that may
reduce risk, such as exercising regularly and
maintaining a healthy weight. Secondary pre-
vention strategies focus on early detection of
cancer by promoting regular screening and
awareness of symptoms of cancer in order to
provide medical intervention at early, curable
stages of disease, However, these strategies are
not 100% effective, and currently no known
prevention strategies will completely eliminate
all risk for developing or dying from breast or
ovarian cancer.
Despite the need for improved breast cancer
detection in younger women, annual screening
mammography, which has been shown to
decrease breast cancer mortality and morbidity
in women over age 40, is not recommended to
average risk women between the ages of 30-39.
This is because the low incidence of breast
cancer, combined with a 10-15% lower mam-
mographic sensitivity in women under age 40
does not support routine screening of average
risk young women using mammography. Be-
cause no screening technology currently ad-
dresses the population of women under age 40,
Clinical Breast Exam (CBE) is the only modal-
ity that is routinely used to screen this popula-
tion. CBE, however, is limited in this capacity
because it is not considered sensitive for small
lesions, is highly dependent upon the examiner,
and is difficult to compare from year to year.
Accordingly, studies show that most women
under 40 detect their own cancers, with
self-detected cancers occurring at a relatively
advanced stage.7, 8
In general, delayed detection leads to more
aggressive and costly treatment regimens as
well as greater morbidity and lower survival
rates.9,10 Mammography screening is offered to
women under the age of 40 if they have known
familial, genetic, or personal risk factors. But, it
should be recognized that the vast majority of
women who develop breast cancer (90%) do not
have one of these known risk factors, and thus
they are generally screened with clinical and/
or self breast exam only.11-13
Because the reliance upon known risk factors
as a criterion for additional screening can be
used as a way to identify some women who
develop breast cancer, we set up a screening
program, a combination of breast examination
by an expert physician and evaluation of risk
factors on 109 personel staff on April 2008.The
use of risk assessment methods can identify
elevated breast cancer risk in women who
otherwise would be overlooked by the current
standard of care, but who are likely to benefit
from additional surveillance or imaging.
METHODOLOGY
This study was conducted in April 2008 in
Tehran, Iran. The cases were chosen randomly
from hospital staff. Women with hysterectomy
and artificial menopause were excluded from
the study. Our study was approved by the medi-
cal ethics committee and written consent was
obtained from all participants.
All women were interviewed by one investi-
gator. Demographical and risk factor data were
Breast cancer risk factors
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collected using a short structured questionnaire,
including information on age, educational level,
marital status, occupation, family history of
breast cancer (first-degree relatives), age at me-
narche, parity, oral contraceptive or any other
methods use for contraception, age at first and
last full-term pregnancy, menopausal status, age
at menopause and any changes in breast exami-
nation , such as enlarged lymph nodes in axil-
lary or supra and infraclavicular region, any
palpable lump in each breast and asymmetry
in breast appearance. Women were classified
as menopausal if they had not menstruated
during the six months before the date of data
collection. A full-term pregnancy was a
pregnancy lasting eight months or longer.
RESULTS
In all, 109 women of hospital personnel were
interviewed.Of this 81.7% of participants
worked in clinical sections of hospital, and
18.3% worked in non-clinical sections. We
divided risk factors for breast cancer into two
groups to hereditary risk factor (non-modifi-
able) and modifiable ones.
A summary of hereditary risk factors for
breast cancer such as mean age of participants,
their marital status, the mean age at marriage,
regularity of menstrual periods, mean parity
time, the mean age for menarche, mean meno-
pause age and positive history of breast cancer
in the family are reflected in Table-I. None of
the participants gave a history of smoking. The
mean duration time for breastfeeding in women
was 23.27±14.16 months, (ranging 1 to 84
months) with regard the fact that some women
S.H. Yahyazadeh et al.
Table-I:  Non-modifiable Risk factors for breast
cancer in 109 participants
Risk factors Values
Age groups (Mean) 40.48 ± 0.56
Age at menarche (Mean) 13.34 ±1.47
Parity
   Parous 87(79.8%)
   Nulliparous 22(20.2%)
Mean age at first 24.56±4.31
   full term pregnancy
Mean age at second 30.38 ± 5.25
  full term  pregnancy
Menopausal status
 Premenopausal 100 (91.7%)
 Postmenopausal 9 (8.3%)
 Mean age at menopause 46.89 ± 4.98
Menstruation condition
   Regular 77.4%
   Irregular 22.6%
Pregnancy  times
   1 17 (19.5%)
   2 41 (47.1%)
   3 17 (19.5%)
   >3 12 (13.8%)
  Mean ± SD 2.36 ± 1.13
History for breast cancer in family
   Yes 9 (8.3%)
   No 100 (91.7%)
Marital status
   Married 85 (87%)
  Widowed/divorced 22 (20.2%)
  Never married 2 (1.8%)
Figure-1: The graph shows the risk factors for breast
cancer. The sum exceeds 100%, because some women
had two or more risk factors at the same time.
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had more than a child, or they did not feed their
child for whole two years, as it is custom in
Iranian population.  Moreover, 28.4% of women
gave a history of previous abortion.
Table-II reflects non-modifiable risk factors
such as the education level for staff, contracep-
tion use methods, Hormone Replace Therapy
(HRT) after menopause and regular mammog-
raphy screening, The participants were exam-
ined to detect any asymmetry, palpable lump,
enlarged lymph node in infra and supraclav-
icular or axillary region, asymmetry, local in-
flammation, discharge or deformity. Eleven
patients (10.1%) had breast mass in radiologi-
cal findings, mostly suggesting fibrocystic
change. In 20.2% of participants, further inves-
tigation was advised. (Table-II) In Figures I &
II, we ordered risk factors by modifiable and
non-modifiable and their frequency.
DISCUSSION
Breast cancer patients in Iran are rather
younger, and the results of previous studies
about breast cancer in Iran, suggest that
singularity and a positive family history of
breast cancer are potential risk factors for breast
cancer in Iranian women. These results approve
other surveys that positive family history of
breast cancer is a strong risk factor for
Table-II:  Modifiable risk factors for
breast cancer in 109 participants
Risk factors Frequency (%)
Educational level
  Illiterate 20.2%
  Diploma 31.7%
  University 48.1%
HRT replacement after menopause
   Yes 3 (33.3)
    No 6 (66.7)
Contraceptive methods
   No methods 16 (14.7)
   OCP 6 (5.5)
   IUD 19 (17.4)
   Other methods 68 (62.4)
History of previous mammography
   No 83 (76.1)
  One time 21 (19.3)
  Two times 4 (3.7)
  Three times 1 (0.9)
Palpable mass in breast exam
   Yes 4 (3.7)
   No 105 (96.3)
Breast mass in radiography
   Yes 11 (10.1)
   No 98 (89.9)
Further advised medial investigation
  No further investigatio 87 (79.8)
  Mammography 15 (13.8)
  Mammography + FNA 1 (0.9)
  FNA 2 (1.8)
  Sonography 3 (2.8)
  Excisional biopsy 1 (0.9)
Figure-2: The graph shows the risk factors for
breast cancer (modifiable and non-modifiable).
Breast cancer risk factors
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breast cancer at young age,14 although it has
been stated that this has a little effect on the
patients survival and mortality from breast
cancer.15
On the other hand, according to the findings
from the studies conducted in Iran, it might be
considered that the relatively high proportion
of young breast cancer cases in Iran is most
likely due to a young population structure and
to a combination of high age at menarche and
low age at first pregnancy.
A study from the United States16 also points
to the matter that in some Asian subgroups such
as the Vietnamese, women diagnosed with
breast cancer tend to be younger than those from
other ethnic groups, with half of the diagnoses
occurring in women younger than 50 years.
Never married women have higher risk for
breast cancer. In most studies single and
nulliparous married women were found to have
a similar increased risk for breast cancer as c
ompared with parous women of the same age.17
It may be imagined that marital status is not a
determining factor for increased or reduced
breast cancer risk, and rather the main
protective effect is from early first full-term
pregnancy. Furthermore, some studies suggest
that there is a relation between marital status
and parity,18 indicating enhanced effect of
parity on breast cancer risk with pregnancy.
Studies have proven the probable relation
between age, family history of breast cancer and
parity.19
In addition, studies have reported that
nulliparity reduces risk for breast cancer at
younger age and elevates risk in the elderly.20,21
For example, studies have proved that breast
cancer is higher risk related in women with a
positive family history who take oral contracep-
tive.22,23 Even though the results cannot be gen-
eralized, the studies done in Iran to determine
a pattern for breast cancer, suggest the associa-
tions between some known risk factors for
breast cancer may differ in Iran as compared
with Western countries, and that familial breast
cancer in young Iranian breast cancer patients
deserves further investigation.
ACKNOWLEDGMENT
We are grateful to Sanofi Aventis Iran for
supporting this research project.
REFERENCES
1. Kerlikowske K, Carney PA, Geller B, Mandelson MT,
Teplin SH, Malvin K, et al. Performance of screening
mammography among women with and without a
first-degree relative with breast cancer. Ann Int Med
2000; 133:856-863.
2. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster
V. Positive predictive value of screening mammogra-
phy by age and family history of breast cancer. JAMA
1993;270:2444-2450.
3. Bobo JK, Lee NC, Thames SF. Findings from 752081
clinical breast examinations reported to a national
screening program from 1995 through 1998. J Nat
Cancer Ins 2000;92:971-976.
4. American Cancer Society: Estimated new cancer cases
and deaths by gender, United States, 2002, Cancer
Facts and Figures 2002.
5. Bassett LW, Jackson VP, Jahan R, Fu YS, Gold RH, eds.
WB Saunders, 127-140. National Cancer Institute (NCI)
2004. Fact Book.
6. American Cancer Society (ACS). Breast Cancer Facts
& Figures 2003-2004.
7. Park BW, Kim SI, Kim MH, Kim EK, Park SH, Lee KS.
Clinical breast examination for screening of asymp-
tomatic women: The importance of clinical breast ex-
amination for breast cancer detection. Yonsei Med J
2000;41:312-318.
8. Zabicki K, Colbert JA, Dominguez FJ, Gadd MA,
Hughes KS, Jones JL, et al. Breast cancer diagnosis in
women </= 40 versus 50 to 60 years: Increasing size
and stage disparity compared with older women over
time. Ann Surg Oncol 2006;13:1072-1077.
9. Tabár L, Duffy SW, Vitak B, Chen HH, Prevost TC.
The natural history of breast carcinoma: What have
we learned from screening? Cancer 1999;86:449–462.
10. Kroenke CH, Rosner B, Chen WY, Kawachi I, Colditz
GA, Holmes MD. Functional impact of breast cancer
by age at diagnosis. J Clin Oncol 2004;22:1849-1856.
11. Pharoah PD, Lipscombe JM, Redman KL, Day NE,
Easton DF, Ponder BA. Familial predisposition to
breast cancer in a British population. Eur J Cancer
2000;36:773-779.
12. Hall IJ, Burke W, Coughlin S, Lee NC. Population
based estimates of family history or breast cancer
among women. Comm Genet 2001;4:134-142.
13. Verkooijen HM, Chappuis PO, Rapiti E, Vlastos G,
Fioretta G, Sarp S, et al. Impact of familial risk factors
on management and survival of early-onset breast
cancer: A population-based study. Br J Cancer
2006;94:231-238.
S.H. Yahyazadeh et al.
   Pak J Med Sci   2010   Vol. 26   No. 2      www.pjms.com.pk   293
Breast cancer risk factors
14. LinksSivell S, Iredale R, Gray J, Coles B. Cancer
genetic risk assessment for individuals at risk of
familial breast cancer. Cochrane Database Syst Rev
2007;(2):CD003721.
15. Collaborative Group on Hormonal Factors in Breast
Cancer. Familial breast cancer: Collaborative
reanalysis of individual data from 52 epidemiological
studies including 58209 women with breast cancer and
101986 women without the disease. Lancet
2001;358:1389–1399.
16. Lin SS, Phan JC, Lin AY. Breast cancer characteristics
of Vietnamese women in the Greater San Francisco
Bay Area. West J Med 2002;176:87–91.
17. Margolis KL, Mucci L, Braaten T, Kumle M, Trolle
Lagerros Y, Adami HO, et al. Physical activity in dif-
ferent periods of life and the risk of breast cancer: The
Norwegian-Swedish Women’s Lifestyle and Health
cohort study. Cancer Epidemiol Biomarkers Prev
2005;14:27-32.
18. LinksJeffreys M, Warren R, Gunnell D, McCarron P,
Smith GD.Life course breast cancer risk factors and
adult breast density (United Kingdom).Cancer Causes
Control 2004;15:947-55.
19. Andrieu N, Prevost T, Rohan TE, Luporsi E, Le MG,
Gerber M, et al. Variation in the interaction between
familial and reproductive factors on the risk of breast
cancer according to age, menopausal status, and de-
gree of familiality. Int J Epidemiol 2000;29:214–223.
20. Sidoni A, Cavaliere A, Bellezza G, Scheibel M,
Bucciarelli E. Breast cancer in young women: clinico-
pathological features and biological specificity. Breast
2003;12:247-250.
21. Antoniou AC, Shenton A, Maher ER, Watson E, Wood-
ward E, Lalloo F, et al. Parity and breast cancer risk
among BRCA1 and BRCA2 mutation carriers. Breast
Cancer Res 2006;8:R72.
22. Tavani A, Gallus S, La Vecchia C, Negri E, Montella
M, Dal Maso L, et al. Risk factors for breast
cancer in women under 40 years. Eur J Cancer
1999;35:1361–1367.
23. Grabrick DM, Hartmann LC, Cerhan JR, Vierkant RA,
Therneau TM, Vachon CM, et al. Risk of breast cancer
with oral contraceptive use in women with a family






Iran University of Medical Science
2. S.H. Yahyazadeh,
Department of Radiation Oncology (Omid)
3. F.Bahoor,




Department of Breast Surgery
6. N. Jafarnia,
Department of Radiation Oncology (Omid)
7. S. Asadi,
Department of Radiation Oncology (Omid)
2-4: Fayazbakhsh Hospital, SSO,
Tehran, Iran.
